Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

Lung cancer is the leading cause of cancer deaths worldwide, mainly because it gets detected late. The discovery by the ...

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.

The Koitas left their corporate careers for philanthropy. Through the Koita Foundation, they use technology to strengthen outcomes in health care and non-profits ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.

Panaji: For the first time in India, Goa govt, semi-govt hospitals and private hospitals will come together to conduct research to find out whether ayurveda-based treatment can be an alternative for ...

The US approved its first CAR T-cell therapy in 2017. China rolled out its own by 2021. But India neither had an approved ...

The Longevity India Conference 2025 - Rise for Healthy Aging, hosted at the Indian Institute of Science (IISc), concluded its final day with impactful discussions on longevity science. The discussions ...

Goa CM Pramod Sawant said blood samples of more than 1 lakh people would be collected as part of the study, and diagnosis ...

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) has released the 2025 Recruitment Notification for ...